Blue Owl Capital Holdings LP

Investment Portfolio & 13F Holdings Analysis

About

Type: FundHoldings: 74Value: $310.1MLatest: 2025Q1

Blue Owl Capital Holdings LP is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 74 holdings worth $0.3 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "CNTA",
  null,
  "OBDC",
  "TNGX",
  "TRML",
  "NCDL",
  "LRMR",
  "MLYS",
  "ADCT",
  "KROS",
  null,
  null,
  null,
  "MRKR",
  null,
  "PVLA",
  "RPTX",
  "SGMT",
  null,
  null,
  null,
  null,
  null,
  null,
  null,
  "BSLKW",
  null,
  null,
  null,
  null,
  "WALDW",
  null,
  "AMODW",
  "BTMWW",
  null,
  null,
  null,
  "NN",
  null,
  null,
  null,
  null,
  "AQST",
  "PLRX",
  null,
  null,
  null,
  null,
  null,
  "GOCO",
  "ROIV",
  null,
  "BNAIW",
  "CAH",
  null,
  "CMPS",
  "CNTX",
  "ELDN",
  "ETWO",
  "EVCM",
  "EYPT",
  "IKNA",
  "INZY",
  "VRNA",
  null,
  "HLLY",
  "RARE",
  "CNDT",
  "CMPX",
  "CRML",
  "CGEM",
  "IRON",
  "EPD"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 74
Total Value: 310078266
Accession Number: 0000950123-25-005588
Form Type: 13F-HR
CIK: blue-owl-capital-holdings-lp
Manager Name: Blue-Owl-Capital-Holdings-Lp

Data Enrichment

57% identified

42 identified32 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

74 positions • $310.1M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 1 of 4

Sort by:

Nuveen Churchill Direct Lending Corp.

NCDL|67090S108

Shares:4.0M

Value:$68.6M

% of Portfolio:22.1% ($68.6M/$310.1M)

Blue Owl Capital Corp

OBDC|69121K104

Shares:2.0M

Value:$30.0M

% of Portfolio:9.7% ($30.0M/$310.1M)

Cullinan Therapeutics, Inc.

CGEM|230031106

Shares:2.4M

Value:$18.4M

% of Portfolio:5.9% ($18.4M/$310.1M)

EverCommerce Inc.

EVCM|29977X105

Shares:1.6M

Value:$16.6M

% of Portfolio:5.3% ($16.6M/$310.1M)

Tourmaline Bio, Inc.

TRML|89157D105

Shares:1.0M

Value:$15.8M

% of Portfolio:5.1% ($15.8M/$310.1M)

CONDUENT Inc

CNDT|206787103

Shares:5.7M

Value:$15.4M

% of Portfolio:5.0% ($15.4M/$310.1M)

29286M105

Shares:3.3M

Value:$14.7M

% of Portfolio:4.7% ($14.7M/$310.1M)

Holley Inc.

HLLY|43538H103

Shares:5.3M

Value:$13.7M

% of Portfolio:4.4% ($13.7M/$310.1M)

Larimar Therapeutics, Inc.

LRMR|517125100

Shares:4.8M

Value:$10.3M

% of Portfolio:3.3% ($10.3M/$310.1M)

74347X831

Shares:175.0K

Value:$10.0M

% of Portfolio:3.2% ($10.0M/$310.1M)

17878Y207

Shares:348.2K

Value:$8.0M

% of Portfolio:2.6% ($8.0M/$310.1M)

Disc Medicine, Inc.

IRON|254604101

Shares:140.3K

Value:$7.0M

% of Portfolio:2.2% ($7.0M/$310.1M)

Eledon Pharmaceuticals, Inc.

ELDN|28617K101

Shares:1.8M

Value:$6.2M

% of Portfolio:2.0% ($6.2M/$310.1M)

Compass Therapeutics, Inc.

CMPX|20454B104

Shares:3.0M

Value:$5.6M

% of Portfolio:1.8% ($5.6M/$310.1M)

Ultragenyx Pharmaceutical Inc.

RARE|90400D108

Shares:153.2K

Value:$5.5M

% of Portfolio:1.8% ($5.5M/$310.1M)

Ikena Oncology, Inc.

IKNA|45175G108

Shares:4.1M

Value:$5.2M

% of Portfolio:1.7% ($5.2M/$310.1M)

Centessa Pharmaceuticals plc

CNTA|152309100

Shares:315.0K

Value:$4.5M

% of Portfolio:1.5% ($4.5M/$310.1M)

Context Therapeutics Inc.

CNTX|21077P108

Shares:7.4M

Value:$4.5M

% of Portfolio:1.5% ($4.5M/$310.1M)

Sagimet Biosciences Inc.

SGMT|786700104

Shares:1.3M

Value:$4.3M

% of Portfolio:1.4% ($4.3M/$310.1M)

EyePoint Pharmaceuticals, Inc.

EYPT|30233G209

Shares:797.6K

Value:$4.3M

% of Portfolio:1.4% ($4.3M/$310.1M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Nuveen Churchill Direct Lending Corp.(NCDLcusip67090S108)	4.0M	QoQ 0.00% (+0) YoY NEW(+4.0M)	All Managers (Combined)	$68.6M	22.1% ($68.6M/$310.1M)	QoQ +1.19% (+$807.9K) YoY NEW(+$68.6M)
Blue Owl Capital Corp(OBDCcusip69121K104)	2.0M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$30.0M	9.7% ($30.0M/$310.1M)	QoQ -3.04% (-$940.7K) YoY -4.68% (-$1.5M)
Cullinan Therapeutics, Inc.(CGEMcusip230031106)	2.4M	QoQ +2.74% (-65.0K) YoY -16.71% (-488.9K)	All Managers (Combined)	$18.4M	5.9% ($18.4M/$310.1M)	QoQ -36.14% (-$10.4M) YoY -63.00% (-$31.4M)
EverCommerce Inc.(EVCMcusip29977X105)	1.6M	QoQ 0.00% (-0) YoY 0.00% (+0)	All Managers (Combined)	$16.6M	5.3% ($16.6M/$310.1M)	QoQ -8.44% (-$1.5M) YoY +7.00% (+$1.1M)
Tourmaline Bio, Inc.(TRMLcusip89157D105)	1.0M	QoQ -3.91% (-42.2K) YoY -28.34% (-410.3K)	All Managers (Combined)	$15.8M	5.1% ($15.8M/$310.1M)	QoQ -27.93% (-$6.1M) YoY -50.69% (-$16.2M)
CONDUENT Inc(CNDTcusip206787103)	5.7M	QoQ +1.27% (-72.0K) YoY NEW(+5.7M)	All Managers (Combined)	$15.4M	5.0% ($15.4M/$310.1M)	QoQ -32.31% (-$7.3M) YoY NEW(+$15.4M)
(cusip29286M105)✕	3.3M	QoQ +3.77% (-119.4K) YoY +33.23% (-818.0K)	All Managers (Combined)	$14.7M	4.7% ($14.7M/$310.1M)	QoQ -30.08% (-$6.3M) YoY -64.78% (-$27.0M)
Holley Inc.(HLLYcusip43538H103)	5.3M	QoQ +77.84% (+2.3M) YoY NEW(+5.3M)	All Managers (Combined)	$13.7M	4.4% ($13.7M/$310.1M)	QoQ +51.34% (+$4.6M) YoY NEW(+$13.7M)
Larimar Therapeutics, Inc.(LRMRcusip517125100)	4.8M	QoQ +2.68% (-125.0K) YoY +19.61% (-783.6K)	All Managers (Combined)	$10.3M	3.3% ($10.3M/$310.1M)	QoQ -42.95% (-$7.7M) YoY -66.11% (-$20.0M)
(cusip74347X831)✕	175.0K	QoQ NEW(+175.0K) YoY NEW(+175.0K)	All Managers (Combined)	$10.0M	3.2% ($10.0M/$310.1M)	QoQ NEW(+$10.0M) YoY NEW(+$10.0M)
(cusip17878Y207)✕	348.2K	QoQ NEW(+348.2K) YoY NEW(+348.2K)	All Managers (Combined)	$8.0M	2.6% ($8.0M/$310.1M)	QoQ NEW(+$8.0M) YoY NEW(+$8.0M)
Disc Medicine, Inc.(IRONcusip254604101)	140.3K	QoQ +16.63% (-20.0K) YoY -9.66% (-15.0K)	All Managers (Combined)	$7.0M	2.2% ($7.0M/$310.1M)	QoQ -8.68% (-$662.0K) YoY -27.97% (-$2.7M)
Eledon Pharmaceuticals, Inc.(ELDNcusip28617K101)	1.8M	QoQ -7.14% (-140.0K) YoY NEW(+1.8M)	All Managers (Combined)	$6.2M	2.0% ($6.2M/$310.1M)	QoQ -23.59% (-$1.9M) YoY NEW(+$6.2M)
Compass Therapeutics, Inc.(CMPXcusip20454B104)	3.0M	QoQ 0.00% (+0) YoY +4.41% (+125.0K)	All Managers (Combined)	$5.6M	1.8% ($5.6M/$310.1M)	QoQ +31.03% (+$1.3M) YoY +0.19% (+$11.1K)
Ultragenyx Pharmaceutical Inc.(RAREcusip90400D108)	153.2K	QoQ +29.60% (+35.0K) YoY -42.87% (-115.0K)	All Managers (Combined)	$5.5M	1.8% ($5.5M/$310.1M)	QoQ +11.54% (+$574.5K) YoY -55.69% (-$7.0M)
Ikena Oncology, Inc.(IKNAcusip45175G108)	4.1M	QoQ 0.00% (-0) YoY +5.13% (-200.0K)	All Managers (Combined)	$5.2M	1.7% ($5.2M/$310.1M)	QoQ -21.95% (-$1.5M) YoY -5.22% (-$288.8K)
Centessa Pharmaceuticals plc(CNTAcusip152309100)	315.0K	QoQ +43.18% (+95.0K) YoY NEW(+315.0K)	All Managers (Combined)	$4.5M	1.5% ($4.5M/$310.1M)	QoQ +22.92% (+$844.7K) YoY NEW(+$4.5M)
Context Therapeutics Inc.(CNTXcusip21077P108)	7.4M	QoQ +15.88% (-1.0M) YoY NEW(+7.4M)	All Managers (Combined)	$4.5M	1.5% ($4.5M/$310.1M)	QoQ -32.45% (-$2.2M) YoY NEW(+$4.5M)
Sagimet Biosciences Inc.(SGMTcusip786700104)	1.3M	QoQ +0.33% (-4.5K) YoY -20.64% (-345.5K)	All Managers (Combined)	$4.3M	1.4% ($4.3M/$310.1M)	QoQ -27.31% (-$1.6M) YoY -52.26% (-$4.7M)
EyePoint Pharmaceuticals, Inc.(EYPTcusip30233G209)	797.6K	QoQ +19.47% (-130.0K) YoY NEW(+797.6K)	All Managers (Combined)	$4.3M	1.4% ($4.3M/$310.1M)	QoQ -13.08% (-$650.6K) YoY NEW(+$4.3M)